CoChat
Sign Up
Cited by 768Atrial Fibrillation Management and OutcomesCardiac electrophysiology and arrhythmiasCardiac Arrhythmias and Treatments

The DOI matches its Crossref record; 83 of the 85 references it cites were found in a registry or an index.

Epidemiology and natural history of atrial fibrillation: clinical implications

Open access
Chugh, Sumeet S, Blackshear, Joseph L, Shen, Win-Kuang, Hammill, Stephen C, Gersh, Bernard J·2001·Journal of the American College of Cardiology
DOI 10.1016/s0735-1097(00)01107-4
Open this paper in CoChat — free accountOpen PDF

Abstract

With a substantial impact on morbidity and mortality, the growing "epidemic" of atrial fibrillation (AF) intersects with a number of conditions, including aging, thromboembolism, hemorrhage, hypertension and left ventricular dysfunction. Currently, the epidemiology and natural history of AF govern all aspects of its clinical management. The ongoing global investigative efforts toward understanding AF are also driven by epidemiologic findings. New developments, by affecting the natural history of the disease, could eventually alter the nature of decision making in patients with AF. The crucial issue of rate versus rhythm control awaits completion of the AF Follow-up Investigation of Rhythm Management trial. The processes of electrical and structural remodeling that perpetuate AF appear to be reversible. In the era of functional genomics, the molecular basis of this ubiquitous arrhythmia is in the process of being defined. Unraveling the molecular genetics of AF might provide new insights into the structural and electrical phenotypes resulting from genetic mutations and, as such, new approaches to treatment of this arrhythmia at the ion channel and cellular levels. Thus, current adverse trends are superimposed on a background of a rapidly developing knowledge base and potentially exciting new therapeutic options. Consequently, an understanding of the epidemiology and natural history of AF is crucial to the future allocation of resources and the utilization of an expanding range of therapies aimed at reducing the impact of this disease on a changing patient population.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/s0735-1097(00)01107-4

Cites

83 of 83 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 1

  1. Chugh, 1999, Sotalol effects are exaggerated in CHF, J Am Coll Cardiol, 33, 131A

Cited by

Sorted by citations

See all 768

Related

See all

Metadata

Authors
Chugh, S. S., Blackshear, J. L., Shen, W.-K., Hammill, S. C., & Gersh, B. J.
Affiliations
Mayo Clinic (US)
Corresponding author
Gersh, Bernard J
ORCID
Venue
Journal of the American College of Cardiology
Publisher
Elsevier BV
Published
2001-02
Volume
37
Issue
2
Pages
371-378
ISSN
0735-1097 (ISSN-L)
DOI
10.1016/s0735-1097(00)01107-4
OpenAlex
W1988911499
Cited by
768
References
85
Citations by year
2026: 9 · 2025: 22 · 2024: 20 · 2023: 20 · 2022: 22 · 2021: 39 · 2020: 28 · 2019: 30 · 2018: 30 · 2017: 35 · 2016: 47 · 2015: 45 · 2014: 40 · 2013: 49 · 2012: 44
FWCI
3.95
Type
journal article
Language
en
Open access
Licence
Locations
  • Journal of the American College of Cardiology (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Atrial Fibrillation Management and Outcomes
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac electrophysiology and arrhythmias
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Arrhythmias and Treatments
Keywords
atrial fibrillation, epidemiology, natural history (disease), thromboembolism, hemorrhage, hypertension, left ventricular dysfunction, aging, electrical remodeling, structural remodeling, molecular genetics, ion channels, antiarrhythmic therapy
MeSH terms
Atrial Fibrillation, Cross-Sectional Studies, Electrocardiography, Humans, Risk Factors, Incidence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review